Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arcus Biosciences Inc (NY: RCUS ) 15.81 +0.83 (+5.54%) Official Closing Price Updated: 7:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Arcus Biosciences Inc < Previous 1 2 3 4 5 Next > Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update July 25, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants July 09, 2024 From Arcus Biosciences Via Business Wire Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia July 08, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants June 25, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants June 11, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers June 10, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 06, 2024 From Arcus Biosciences Via Business Wire Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer June 02, 2024 From Gilead Sciences, Inc. Via Business Wire Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers June 01, 2024 From Gilead Sciences, Inc. Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants May 24, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants May 09, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update May 08, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024 May 02, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting April 24, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update April 23, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants April 09, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants March 26, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants March 11, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Participate in Two Upcoming Investor Conferences February 28, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants February 27, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update February 21, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants February 09, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates February 07, 2024 From Arcus Biosciences Via Business Wire Gilead and Arcus Announce Amended Collaboration and Equity Investment January 29, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants January 26, 2024 From Arcus Biosciences Via Business Wire Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer January 16, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants December 11, 2023 From Arcus Biosciences Via Business Wire Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma December 04, 2023 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants November 27, 2023 From Arcus Biosciences Via Business Wire From laggards to leaders: Small caps on the rise November 27, 2023 Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains. Via MarketBeat < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.